chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: Arthritis Pain improved; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Arthritis Pain improved) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 030M20A) for COVID-19 vaccination.     The patient's past medical history included Knee replacement on 27-Apr-2021. Concomitant products included ETANERCEPT (ENBREL), METHOTREXATE, HYALURONATE SODIUM (EUFLEXXA), CENTRUM SILVER +50, CHONDROITIN SULFATE SODIUM, GLUCOSAMINE HYDROCHLORIDE (GLUCOSAMINE/CHONDROITIN [CHONDROITIN SULFATE SODIUM;GLUCOSAMINE HYDROCHLORIDE]), CALCIUM, ZINGIBER OFFICINALE ROOT (GINGER ROOT EXTRACT), FOLIC ACID, CINNAMOMUM CASSIA BARK, THIOCTIC ACID (CINNAMON ALPHA LIPOIC ACID), BIFIDOBACTERIUM BIFIDUM, BIFIDOBACTERIUM LONGUM, LACTOBACILLUS GASSERI (PHILLIPS COLON HEALTH), OMEPRAZOLE, ROSUVASTATIN, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), VITAMIN D3 and TOCOPHEROL (VITAMIN E [TOCOPHEROL]) for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Arthritis Pain improved). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Arthritis Pain improved) outcome was unknown.            Treatment information was not provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Product dose omission issue
Clinical narrative: Got COVID-19; Did not get second dose yet; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Got COVID-19) and PRODUCT DOSE OMISSION ISSUE (Did not get second dose yet) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. not provided) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Got COVID-19) and PRODUCT DOSE OMISSION ISSUE (Did not get second dose yet). The patient was treated with PLASMA at a dose of 1 dosage form. At the time of the report, COVID-19 (Got COVID-19) and PRODUCT DOSE OMISSION ISSUE (Did not get second dose yet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drugs are provided.  No treatment information was given.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Estimated 30 patients received vaccines from expired vial.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Estimated 30 patients received vaccines from expired vial.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Estimated 30 patients received vaccines from expired vial.). On 22-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Estimated 30 patients received vaccines from expired vial.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Cross linked with MOD21-114724  No Concomitant and  treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: NNI Follow up received/ No adverse event reported
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 8 patients received a dose from a vial that was expired / vial was taken out of the refrigerator at 4:14pm on Monday 21JUN2021 and punctured and kept at room temperature / received doses from the same via yesterday 22JUN2021 between 9am and 6:19pm; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (8 patients received a dose from a vial that was expired / vial was taken out of the refrigerator at 4:14pm on Monday 21JUN2021 and punctured and kept at room temperature / received doses from the same via yesterday 22JUN2021 between 9am and 6:19pm) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (8 patients received a dose from a vial that was expired / vial was taken out of the refrigerator at 4:14pm on Monday 21JUN2021 and punctured and kept at room temperature / received doses from the same via yesterday 22JUN2021 between 9am and 6:19pm). At the time of the report, EXPIRED PRODUCT ADMINISTERED (8 patients received a dose from a vial that was expired / vial was taken out of the refrigerator at 4:14pm on Monday 21JUN2021 and punctured and kept at room temperature / received doses from the same via yesterday 22JUN2021 between 9am and 6:19pm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medications are provided. treatment to the events not provided.  8 patients received a dose from a vial that was expired, Pharmacist states the vial was taken out of the refrigerator at 4:14pm on Monday 21JUN2021 and punctured and kept at room temperature. Some patients received doses from the same vial yesterday 22JUN2021 between 9am and 6:19pm. Of the 8 patients, 6 received the vaccine within 24 hours and 2 patients received it about 26 hours after it was punctured at room temperature. Caller states that none of the patients have reported any adverse events.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Pain in extremity
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of back pain (pain moved to part of right-side of back), pain in extremity (pain in right hand/pain moved to the whole arm) and arthralgia (pain moved to shoulder) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. April 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jun 20, 2021, patient experienced pain in extremity (pain in right hand/pain moved to the whole arm). On Jun 23, 2021, patient experienced back pain (pain moved to part of right-side of back) and arthralgia (pain moved to shoulder). At the time of the report, back pain (pain moved to part of right-side of back), pain in extremity (pain in right hand/pain moved to the whole arm) and arthralgia (pain moved to shoulder) outcome: unknown. No concomitant medication or treatment information provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Musculoskeletal stiffness, Swelling
Clinical narrative: Stiffness; Swelling; Left shoulder became sore; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiffness), SWELLING (Swelling) and ARTHRALGIA (Left shoulder became sore) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness), SWELLING (Swelling) and ARTHRALGIA (Left shoulder became sore). At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiffness), SWELLING (Swelling) and ARTHRALGIA (Left shoulder became sore) outcome was unknown.            No concomitant medications was reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Aug-2021: Non significant FU- updated Mailing Address
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Feeling hot, Malaise, Muscle spasms
Clinical narrative: Leg was cramping; Felt a little warm; Didn't feel well; Heart was racing; Had trouble trying to catch a breath; Immediately go to the bathroom and had diarrhoea; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Didn't feel well), PALPITATIONS (Heart was racing), DYSPNOEA (Had trouble trying to catch a breath), DIARRHOEA (Immediately go to the bathroom and had diarrhoea) and MUSCLE SPASMS (Leg was cramping) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037C21A and 022C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jun-2021, the patient experienced MALAISE (Didn't feel well), PALPITATIONS (Heart was racing), DYSPNOEA (Had trouble trying to catch a breath) and DIARRHOEA (Immediately go to the bathroom and had diarrhoea). On 23-Jun-2021, the patient experienced MUSCLE SPASMS (Leg was cramping) and FEELING HOT (Felt a little warm). On 22-Jun-2021, MALAISE (Didn't feel well), PALPITATIONS (Heart was racing), DYSPNOEA (Had trouble trying to catch a breath) and DIARRHOEA (Immediately go to the bathroom and had diarrhoea) outcome was unknown. At the time of the report, MUSCLE SPASMS (Leg was cramping) and FEELING HOT (Felt a little warm) outcome was unknown.            No concomitant medications were provided. No treatment details were provided.   Reporter did not allow further contact
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: Leg was cramping; Felt a little warm; Didn't feel well; Heart was racing; Had trouble trying to catch a breath; Immediately go to the bathroom and had diarrhoea; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Didn't feel well), PALPITATIONS (Heart was racing), DYSPNOEA (Had trouble trying to catch a breath), DIARRHOEA (Immediately go to the bathroom and had diarrhoea) and MUSCLE SPASMS (Leg was cramping) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037C21A and 022C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jun-2021, the patient experienced MALAISE (Didn't feel well), PALPITATIONS (Heart was racing), DYSPNOEA (Had trouble trying to catch a breath) and DIARRHOEA (Immediately go to the bathroom and had diarrhoea). On 23-Jun-2021, the patient experienced MUSCLE SPASMS (Leg was cramping) and FEELING HOT (Felt a little warm). On 22-Jun-2021, MALAISE (Didn't feel well), PALPITATIONS (Heart was racing), DYSPNOEA (Had trouble trying to catch a breath) and DIARRHOEA (Immediately go to the bathroom and had diarrhoea) outcome was unknown. At the time of the report, MUSCLE SPASMS (Leg was cramping) and FEELING HOT (Felt a little warm) outcome was unknown.            No concomitant medications were provided. No treatment details were provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: get sick from the second shot two weeks after getting it; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (get sick from the second shot two weeks after getting it) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (get sick from the second shot two weeks after getting it). At the time of the report, ILLNESS (get sick from the second shot two weeks after getting it) outcome was unknown.            It has reported that patient had taken the second shot two weeks ago. No concomitant medications were reported. No treatment medication was reported.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Influenza like illness, Myalgia, Pyrexia
Clinical narrative: flu-like symptoms; sweats; fever; chills; body aches; This spontaneous case was reported by a pharmacist and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), HYPERHIDROSIS (sweats), PYREXIA (fever), CHILLS (chills) and MYALGIA (body aches) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022B21A and 022B21A) for COVID-19 vaccination.     The patient's past medical history included Skin cancer and Chemotherapy in 2018. Concurrent medical conditions included High cholesterol. Concomitant products included ROSUVASTATIN for High cholesterol.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), HYPERHIDROSIS (sweats), PYREXIA (fever), CHILLS (chills) and MYALGIA (body aches). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), HYPERHIDROSIS (sweats), PYREXIA (fever), CHILLS (chills) and MYALGIA (body aches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Knee has gotten worse; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Knee has gotten worse) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis (She had been diagnosed with arthritis of the knee years ago.).   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Knee has gotten worse). At the time of the report, ARTHRALGIA (Knee has gotten worse) outcome was unknown.            No concomitant product use was provided by the reporter. Treatment information was not provided.  The consumer stated that she was having a knee replacement surgery in September 2021 due to arthritis. The patient received 2nd dose of Vaccination in February 2021.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Abnormal faeces, Dizziness, Feeling abnormal, Heart rate increased, Musculoskeletal stiffness
Clinical narrative: stiff neck / really stiff neck; felt really bad; 103 fever / fever; bowel movement that really smelled, nasty like sludge; queasy; real dizzy; fell asleep three times since I've been home; heart rate is elevated; I feel pounding in my chest; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiff neck / really stiff neck), FEELING ABNORMAL (felt really bad), PYREXIA (103 fever / fever), ABNORMAL FAECES (bowel movement that really smelled, nasty like sludge) and NAUSEA (queasy) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jun-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (stiff neck / really stiff neck), FEELING ABNORMAL (felt really bad), PYREXIA (103 fever / fever), ABNORMAL FAECES (bowel movement that really smelled, nasty like sludge), NAUSEA (queasy), DIZZINESS (real dizzy), SOMNOLENCE (fell asleep three times since I've been home), HEART RATE INCREASED (heart rate is elevated) and PALPITATIONS (I feel pounding in my chest). The patient was treated with PARACETAMOL (TYLENOL) on 23-Jun-2021 at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL STIFFNESS (stiff neck / really stiff neck), FEELING ABNORMAL (felt really bad), PYREXIA (103 fever / fever), ABNORMAL FAECES (bowel movement that really smelled, nasty like sludge), NAUSEA (queasy), DIZZINESS (real dizzy), SOMNOLENCE (fell asleep three times since I've been home), HEART RATE INCREASED (heart rate is elevated) and PALPITATIONS (I feel pounding in my chest) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant Medications was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow-up information received on 23-JUN-2021 contains no significant information.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Palpitations, Pyrexia, Somnolence
Clinical narrative: stiff neck / really stiff neck; felt really bad; 103 fever / fever; bowel movement that really smelled, nasty like sludge; queasy; real dizzy; fell asleep three times since I've been home; heart rate is elevated; I feel pounding in my chest; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiff neck / really stiff neck), FEELING ABNORMAL (felt really bad), PYREXIA (103 fever / fever), ABNORMAL FAECES (bowel movement that really smelled, nasty like sludge) and NAUSEA (queasy) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jun-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (stiff neck / really stiff neck), FEELING ABNORMAL (felt really bad), PYREXIA (103 fever / fever), ABNORMAL FAECES (bowel movement that really smelled, nasty like sludge), NAUSEA (queasy), DIZZINESS (real dizzy), SOMNOLENCE (fell asleep three times since I've been home), HEART RATE INCREASED (heart rate is elevated) and PALPITATIONS (I feel pounding in my chest). The patient was treated with PARACETAMOL (TYLENOL) on 23-Jun-2021 at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL STIFFNESS (stiff neck / really stiff neck), FEELING ABNORMAL (felt really bad), PYREXIA (103 fever / fever), ABNORMAL FAECES (bowel movement that really smelled, nasty like sludge), NAUSEA (queasy), DIZZINESS (real dizzy), SOMNOLENCE (fell asleep three times since I've been home), HEART RATE INCREASED (heart rate is elevated) and PALPITATIONS (I feel pounding in my chest) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant Medications was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow-up information received on 23-JUN-2021 contains no significant information.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain). At the time of the report, PAIN IN EXTREMITY (arm pain) outcome was unknown.            No concomitant medications information was reported. No treatment medications were provided.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Irritability, Myalgia, Vaccination site pain
Clinical narrative: Pain is not deliberating, but annoying; injection site is still sore. He says that it is sore enough that he cannot sleep on that side. He says; He says he has sore muscle feeling; This spontaneous case was reported by a consumer and describes the occurrence of IRRITABILITY (Pain is not deliberating, but annoying), VACCINATION SITE PAIN (injection site is still sore. He says that it is sore enough that he cannot sleep on that side. He says) and MYALGIA (He says he has sore muscle feeling) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IRRITABILITY (Pain is not deliberating, but annoying), VACCINATION SITE PAIN (injection site is still sore. He says that it is sore enough that he cannot sleep on that side. He says) and MYALGIA (He says he has sore muscle feeling). At the time of the report, IRRITABILITY (Pain is not deliberating, but annoying), VACCINATION SITE PAIN (injection site is still sore. He says that it is sore enough that he cannot sleep on that side. He says) and MYALGIA (He says he has sore muscle feeling) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of illness (got sick after 2nd shot) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced illness (got sick after 2nd shot). At the time of the report, illness (got sick after 2nd shot) outcome: unknown. No concomitant medication or treatment information reported. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: I recieved my first dose 4/28 is it to late for second?; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I recieved my first dose 4/28 is it to late for second?) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I recieved my first dose 4/28 is it to late for second?). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I recieved my first dose 4/28 is it to late for second?) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No information regarding corrective treatment was reported by the patient.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 year old received both doses of Moderna vaccine, no side effects reported; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received both doses of Moderna vaccine, no side effects reported) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037C21A and 037C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received both doses of Moderna vaccine, no side effects reported). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received both doses of Moderna vaccine, no side effects reported) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness postural, Sinusitis
Clinical narrative: sinus infection; dizziness/ dizziness that hasn't let up/ I bend over, I'm dizzy/I reach up to get something, I'm dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS POSTURAL (dizziness/ dizziness that hasn't let up/ I bend over, I'm dizzy/I reach up to get something, I'm dizzy) and SINUSITIS ( sinus infection) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006C21A and 007B21A) for COVID-19 vaccination.     The patient's past medical history included Hiatal hernia and Chest pain.   On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced DIZZINESS POSTURAL (dizziness/ dizziness that hasn't let up/ I bend over, I'm dizzy/I reach up to get something, I'm dizzy). On an unknown date, the patient experienced SINUSITIS ( sinus infection). The patient was treated with AMOXICILLIN for Sinus infection, at a dose of 1 dosage form; CEFTRIAXONE SODIUM (ROCEPHIN) for Sinus infection, at a dose of 1 dosage form and MECLIZINE [MECLOZINE] for Dizziness, at a dose of 1 dosage form. At the time of the report, DIZZINESS POSTURAL (dizziness/ dizziness that hasn't let up/ I bend over, I'm dizzy/I reach up to get something, I'm dizzy) had not resolved and SINUSITIS ( sinus infection) had resolved.            Action taken with mRNA 1273 in response to event was not applicable. Patient Concomitant medication includes unspecified blood pressure medication,unspecified cholesterol medication,unspecified allergy pill,acid reflux medication.   This case was linked to MOD-2021-234035, MOD-2021-234035 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Hypoaesthesia, Mobility decreased, Tenderness
Clinical narrative: Numbness in the arm; Tenderness; Hard to move my arm; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness in the arm), TENDERNESS (Tenderness) and MOBILITY DECREASED (Hard to move my arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Numbness in the arm), TENDERNESS (Tenderness) and MOBILITY DECREASED (Hard to move my arm). At the time of the report, HYPOAESTHESIA (Numbness in the arm), TENDERNESS (Tenderness) and MOBILITY DECREASED (Hard to move my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment information was not provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: fever; body aches; chill; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), MYALGIA (body aches) and CHILLS (chill) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever), MYALGIA (body aches) and CHILLS (chill). At the time of the report, PYREXIA (fever), MYALGIA (body aches) and CHILLS (chill) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were provided. No medical history was provided.
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Decreased appetite, Fatigue, Inappropriate schedule of product administration, Pyrexia
Clinical narrative: second dose of vaccine 14 days after she would be tested negative for Covid.; SARS-CoV-2 test; a fever that came and went; fatigue; loss of appetite; a cough; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (loss of appetite), COUGH (a cough), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose of vaccine 14 days after she would be tested negative for Covid.), SARS-COV-2 TEST (SARS-CoV-2 test) and PYREXIA (a fever that came and went) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jun-2021, the patient experienced DECREASED APPETITE (loss of appetite), COUGH (a cough), PYREXIA (a fever that came and went) and FATIGUE (fatigue). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose of vaccine 14 days after she would be tested negative for Covid.) and SARS-COV-2 TEST (SARS-CoV-2 test). On 20-Jun-2021, PYREXIA (a fever that came and went) had resolved. At the time of the report, DECREASED APPETITE (loss of appetite), COUGH (a cough), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose of vaccine 14 days after she would be tested negative for Covid.), SARS-COV-2 TEST (SARS-CoV-2 test) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medications were not reported.  Treatment medication was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Updated reporter email . Event COVID 19
Age: 95.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: second dose of vaccine 14 days after she would be tested negative for Covid.; SARS-CoV-2 test; a fever that came and went; fatigue; loss of appetite; a cough; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (loss of appetite), COUGH (a cough), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose of vaccine 14 days after she would be tested negative for Covid.), SARS-COV-2 TEST (SARS-CoV-2 test) and PYREXIA (a fever that came and went) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jun-2021, the patient experienced DECREASED APPETITE (loss of appetite), COUGH (a cough), PYREXIA (a fever that came and went) and FATIGUE (fatigue). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose of vaccine 14 days after she would be tested negative for Covid.) and SARS-COV-2 TEST (SARS-CoV-2 test). On 20-Jun-2021, PYREXIA (a fever that came and went) had resolved. At the time of the report, DECREASED APPETITE (loss of appetite), COUGH (a cough), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose of vaccine 14 days after she would be tested negative for Covid.), SARS-COV-2 TEST (SARS-CoV-2 test) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medications were not reported.  Treatment medication was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Updated reporter email . Event COVID 19
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Feeling hot, Pain in extremity, Paraesthesia
Clinical narrative: Warmth sensation came over her body; Burning lower back pain; Her legs feel tingly; Arms hurt; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Warmth sensation came over her body), BACK PAIN (Burning lower back pain), PARAESTHESIA (Her legs feel tingly) and PAIN IN EXTREMITY (Arms hurt) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diverticulosis. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for an unknown indication.    On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jun-2021, the patient experienced FEELING HOT (Warmth sensation came over her body), BACK PAIN (Burning lower back pain), PARAESTHESIA (Her legs feel tingly) and PAIN IN EXTREMITY (Arms hurt). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form. At the time of the report, FEELING HOT (Warmth sensation came over her body), BACK PAIN (Burning lower back pain), PARAESTHESIA (Her legs feel tingly) and PAIN IN EXTREMITY (Arms hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Illness, Influenza like illness, Myalgia, Pyrexia
Clinical narrative: felt like he had the flu; felt sick; Headache; fever; Aches; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (felt like he had the flu), ILLNESS (felt sick), HEADACHE (Headache), PYREXIA (fever) and MYALGIA (Aches) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medication history was reported by the provider.  Concomitant products included CHLORPHENAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE (CORICIDIN HBP COUGH & COLD), PARACETAMOL (TYLENOL) and NAPROXEN SODIUM (ALEVE) for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (felt like he had the flu), ILLNESS (felt sick), HEADACHE (Headache), PYREXIA (fever) and MYALGIA (Aches). On 13-Feb-2021, INFLUENZA LIKE ILLNESS (felt like he had the flu), ILLNESS (felt sick), PYREXIA (fever) and MYALGIA (Aches) had resolved. At the time of the report, HEADACHE (Headache) was resolving.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment medications were reported.   This case was linked to MOD-2021-232713 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Added demographic details- age, gender and Date of birth
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: sore throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034C21A and 037C21A) for COVID-19 vaccination.     Concurrent medical conditions included Hay fever.   On 24-May-2021 at 4:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-May-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). The patient was treated with PARACETAMOL (TYLENOL) (oral) from 22-Jun-2021 to 26-Jun-2021 for Pain relief, at a dose of 800 mg. On 28-May-2021, OROPHARYNGEAL PAIN (sore throat) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided.  Painful  sore throat treated cough medicines and cough drops and sore throat sprays.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Significant follow up contain reporter contact details, patient demographics, Allergies and event outcome are updated.
Sex: M
Vaccine: COVID19
Symptoms: Sinusitis
Clinical narrative: Sinus infection; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (Sinus infection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Sinus infection. Concurrent medical conditions included Pollen allergy.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SINUSITIS (Sinus infection). The patient was treated with PREDNISONE ongoing since an unknown date for Sinus infection, at an unspecified dose and frequency. At the time of the report, SINUSITIS (Sinus infection) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant product used was not provided by the reporter.  Patient was advised to hold off on the steroid until his second shot of vaccine.  Treatment included local prednisone.   This case was linked to MOD-2021-233333 (Patient Link).
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Medical history was not provided by reporter.  Concomitant products included CHLORPHENAMINE MALEATE, PARACETAMOL (CORICIDIN HBP COLD AND FLU), PARACETAMOL (TYLENOL) and NAPROXEN SODIUM (ALEVE) for an unknown indication.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.            He scheduled for CT scan on 20-july-2021 and see an ear, nose, and throat specialist Physician on 7JUL2021.  Treatment medications were not provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments  Action taken with mRNA-1273 in response to the events was not Applicable   This case was linked to MOD-2021-232656, MOD-2021-233282 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow-up information received on 23-jun-2021 contains no new information.
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: Needle might have leaked out; Believed that she gave 0.3mL or 0.4mL of the dose instead of the full dose; This spontaneous case was reported by a pharmacist and describes the occurrence of DEVICE CONNECTION ISSUE (Needle might have leaked out) and UNDERDOSE (Believed that she gave 0.3mL or 0.4mL of the dose instead of the full dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jun-2021, the patient experienced DEVICE CONNECTION ISSUE (Needle might have leaked out) and UNDERDOSE (Believed that she gave 0.3mL or 0.4mL of the dose instead of the full dose). On 22-Jun-2021, DEVICE CONNECTION ISSUE (Needle might have leaked out) and UNDERDOSE (Believed that she gave 0.3mL or 0.4mL of the dose instead of the full dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information was not provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: No new information
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine injected to patients at Various Pharmacy locations/Drawn up syringe given after 12 hour/administered 3 doses of Moderna Covid-19 Vaccine  to 3  patients which were withdrawn the night before ( more than 12 hours  ago ).; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine injected to patients at Various Pharmacy locations/Drawn up syringe given after 12 hour/administered 3 doses of Moderna Covid-19 Vaccine  to 3  patients which were withdrawn the night before ( more than 12 hours  ago ).) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine injected to patients at Various Pharmacy locations/Drawn up syringe given after 12 hour/administered 3 doses of Moderna Covid-19 Vaccine  to 3  patients which were withdrawn the night before ( more than 12 hours  ago ).). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine injected to patients at Various Pharmacy locations/Drawn up syringe given after 12 hour/administered 3 doses of Moderna Covid-19 Vaccine  to 3  patients which were withdrawn the night before ( more than 12 hours  ago ).) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported. Patient identifier- Group of patients.  Complaint Title :Expiration date on Vial Label Faded( Labelling issue).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Non-Significant Follow-up On 29-Jun-2021: Non-Significant follow up appended to
Sex: U
Vaccine: COVID19
Symptoms: Headache, Nausea, Restlessness
Clinical narrative: Very restless; Mild headache; woke up nauseaous; This spontaneous case was reported by a consumer and describes the occurrence of RESTLESSNESS (Very restless), HEADACHE (Mild headache) and NAUSEA (woke up nauseaous) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RESTLESSNESS (Very restless), HEADACHE (Mild headache) and NAUSEA (woke up nauseaous). At the time of the report, RESTLESSNESS (Very restless), HEADACHE (Mild headache) and NAUSEA (woke up nauseaous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient had mild COVID-19 in march. No concomitant medication was reported.  The treatment information was not given.
Sex: U
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: feel like I am going to throw up; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (feel like I am going to throw up) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VOMITING (feel like I am going to throw up). At the time of the report, VOMITING (feel like I am going to throw up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Concomitant medication not provided.  Treatment information not provided.